Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma
Oral Diseases · 2026
DOI: 10.1111/odi.70420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2026. Verfasst von Puangwan Lapthanasupkul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Mutation, Ameloblastoma, Odontogenic Tumors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to investigate gene mutations in ameloblastic carcinoma (AC) including BRAF , KRAS , and PIK3CA , along with associated protein expressions of BRAF V600E, p‐ERK1/2, and p‐mTOR, which represent activation of MAPK/ERK and PI3K/mTOR pathways, respectively. Materials and Methods Ten formalin‐fixed, paraffin‐embedded AC tissue samples were collected. Tumor area samples were manually micro‐dissected for DNA extraction. All samples then underwent gene amplification using polymerase chain reaction and were subsequently sent for DNA sequencing. The investigation of protein expressions was assessed using immunohistochemistry.
Results
Heterozygous mutations in BRAF , KRAS , and PIK3CA were observed in 40.0%, 30.0%, and 30.0% of AC cases, respectively. Notably, 75.0% of BRAF ‐mutated cases (3/4) co‐harbored either KRAS or PIK3CA mutations. Immunohistochemical analysis revealed BRAF V600E expression in 40.0% of cases. AC also expressed mild immunostaining for p‐ERK1/2 (mean IRS ± SD; 2.50 ± 2.526) and moderate immunostaining for p‐mTOR (mean IRS ± SD; 7.62 ± 2.869), within both the cytoplasm and nucleus of the tumor cells.
Conclusion
The presence of these oncogenic gene mutations and protein expressions suggests that MAPK/ERK and PI3K/mTOR pathways may contribute to AC pathogenesis. However, further studies with larger sample sizes are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Oral Biology and Integrative Biomedical Science Program, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Department of Advanced General Dentistry, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Institute of Pathology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.
- Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Faculty of Dentistry, Burapha University, Chon Buri, Thailand.
ORCID-Profile: Puangwan Lapthanasupkul
Zitieren
APA
Lapthanasupkul, P., Pankam, J., Khovidhunkit, S. P., Seneetuntigul, P., & Kitkumthorn, N. (2026). Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma. Oral Diseases. https://doi.org/10.1111/odi.70420
Vancouver
Lapthanasupkul P, Pankam J, Khovidhunkit SP, Seneetuntigul P, Kitkumthorn N. Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma. Oral Diseases. 2026. doi:10.1111/odi.70420
BibTeX
@article{Lapthanasupkul2026,
author = {Lapthanasupkul, Puangwan and Pankam, Jintana and Khovidhunkit, Siribang-On Piboonniyom and Seneetuntigul, Prapapun and Kitkumthorn, Nakarin},
title = {Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70420}
}
EUVIMED